|
|
|
Corporate Profile:
Adamas Pharmaceuticals
| Summary: |
| Adamas Pharmaceuticals is focused on developing small molecule therapeutics to treat neurological and infectious diseases, including influenza A. |
| Address (HQ): |
2200 Powell Street
Suite 220
Emeryville, CA 94608 |
| Phone #'s (HQ): |
| Main |
(510) 450-3500 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(510) 428-0519 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| ADMS |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
